Machine learning reveals how metabolite profiles predict aging and health

Researchers developed metabolomic aging clocks using machine learning, uncovering links between metabolite profiles, health outcomes, and lifespan.

Vebeglogene autotemcel by Lantu Biopharma for Beta Thalassaemia: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

January 6, 2025

Preterm birth linked to increased mortality risk from infancy to adulthood

Findings indicate preterm birth is associated with elevated mortality risks, especially in early years, influenced by gestational age and health factors.

November 22, 2024

GH Research Provides Updates and Guidance on its Clinical Development Program for GH001 in Treatment-Resistant Depression | Psychedelic Invest

GH Research PLC (Nasdaq: GHRS), a clinical-stage biopharmaceutical company dedicated to transforming the treatment of psychiatric and neurological disorders, today provided updates and guidance on

October 2, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.